Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 150.74B | 136.16B | 129.36B | 127.82B | 117.25B |
Gross Profit | 34.74B | 29.75B | 25.71B | 28.68B | 26.66B |
EBITDA | 15.81B | 13.23B | 13.00B | 16.56B | 15.61B |
Net Income | 6.53B | 4.53B | 4.85B | 7.69B | 7.28B |
Balance Sheet | |||||
Total Assets | 153.93B | 141.68B | 128.44B | 127.37B | 117.39B |
Cash, Cash Equivalents and Short-Term Investments | 22.48B | 32.11B | 30.62B | 28.15B | 24.28B |
Total Debt | 4.67B | 1.65B | 1.99B | 1.97B | 2.72B |
Total Liabilities | 53.23B | 48.04B | 39.16B | 42.15B | 39.45B |
Stockholders Equity | 92.00B | 85.96B | 82.45B | 79.34B | 73.06B |
Cash Flow | |||||
Free Cash Flow | -11.14B | 3.15B | 3.23B | 6.10B | 2.17B |
Operating Cash Flow | 6.59B | 10.08B | 8.37B | 11.40B | 11.89B |
Investing Cash Flow | -17.57B | -6.10B | -3.97B | -5.18B | -9.89B |
Financing Cash Flow | 373.00M | -3.51B | -2.44B | -2.77B | -806.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥68.20B | 11.39 | 7.36% | 2.79% | -10.78% | ||
78 Outperform | ¥56.28B | 9.68 | 4.27% | 3.38% | -15.37% | ||
78 Outperform | ¥55.55B | 8.45 | 2.95% | 4.17% | 22.27% | ||
77 Outperform | ¥28.98B | 13.32 | 4.25% | 5.69% | 4.45% | ||
76 Outperform | ¥79.95B | 11.84 | 7.66% | 2.63% | 6.19% | 32.01% | |
75 Outperform | ¥56.46B | 15.90 | 1.85% | 11.80% | 14.34% | ||
61 Neutral | $17.22B | 11.53 | -5.99% | 3.08% | 1.40% | -15.51% |
ZACROS Corporation announced a series of financial strategies including a 1-for-4 stock split to lower share prices and improve liquidity, effective October 1, 2025. The company also plans to amend its articles of incorporation to increase the total number of authorized shares, revise its dividend forecast, and enhance its shareholder benefits program, aiming to attract long-term investors and expand its investor base.
ZACROS Corporation’s first-quarter financial results for fiscal year 2025 highlight its commitment to enhancing its market position through diverse product offerings across multiple sectors. The company’s focus on innovative solutions in packaging, biomedical, and electronic materials aims to address current societal needs and strengthen its industry presence.
ZACROS Corporation has completed the allocation and payment procedures for the disposal of treasury stock as restricted stock, following a resolution made at their Board of Directors meeting. This disposal involves 6,700 shares allocated to three directors and 8,400 shares to five executive officers, with the shares being issued as compensation without monetary payment, reflecting a strategic move to align management interests with company performance.
ZACROS Corporation has announced a decision by its Board of Directors to dispose of treasury stock as restricted stock for its directors and executive officers. This move is part of a compensation system aimed at enhancing corporate value and aligning interests with shareholders. The disposal involves 15,100 shares of common stock, with directors receiving shares as compensation and executive officers receiving monetary claims to be contributed in kind. This initiative underscores the company’s commitment to sustainable value creation and stakeholder alignment.
ZACROS Corporation, listed on the Prime Market of the Tokyo Stock Exchange, announced changes in its leadership structure, with new appointments to be confirmed at the upcoming Annual General Meeting. These changes reflect a strategic shift in the company’s leadership, potentially impacting its operational focus and stakeholder relations.